NCT05519670 A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05515575 A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05507970 First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367 Status COMPLETED Phase PHASE1
NCT05501522 Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and Older Status COMPLETED Phase PHASE3
NCT05496231 A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age Status COMPLETED Phase PHASE1/PHASE2
NCT05491902 Pilot PET Study of Regional Cerebral Protein Synthesis in Alzheimer's Status TERMINATED Phase N/A
NCT05480800 A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever Status COMPLETED Phase PHASE1/PHASE2
NCT05477186 Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old Status COMPLETED Phase PHASE1
NCT05473195 A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098 Status COMPLETED Phase PHASE2
NCT05448170 Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC) Status AVAILABLE Phase N/A
NCT05446740 A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults Status COMPLETED Phase PHASE1
NCT05442749 Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT05435170 Food Effect Study of Linerixibat Tablets in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT05424380 A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS Status TERMINATED Phase PHASE1
NCT05418868 A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants Status RECRUITING Phase PHASE1
NCT05412030 A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants Status COMPLETED Phase PHASE2
NCT05405192 Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia Status WITHDRAWN Phase PHASE2
NCT05404763 Mepolizumab and Physical Activity in Severe Asthma Status ACTIVE_NOT_RECRUITING Phase N/A